Archived

This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.

Abstract

Background: Individuals with substance use disorders (SUD) have disproportionately higher smoking prevalence and tobacco-related mortality than the general population. This high prevalence of smoking warrants a need for targeted tobacco treatment efforts.

Objectives: To examine smoking cessation outcomes and predictors of successful smoking cessation among individuals with SUD accessing a tobacco dependence clinic (TDC) within Addiction Services.

Methods: Based on clinical guidelines, participants of the TDC received behavioural therapy combined with tailored pharmacotherapy for tobacco treatment (at no cost). A retrospective chart review from 678 participants enrolled in the TDC between Sept 2007 and Dec 2011 was analyzed. 7-day point-prevalence abstinence (validated by expired carbon monoxide) at end-of-treatment was the main outcome measure.

Results: For individuals who completed the program (n=523), the abstinence rate was 40.3%. Significant predictors of successful smoking abstinence at the end-of-treatment were: a) having a lower expired CO level at baseline, and b) staying in treatment for a greater number of weeks.

Conclusions: Tobacco treatment tailored to the needs of individuals with SUD is an important approach to reduce the disproportionate tobacco-related morbidity and mortality in this population. Specialized tobacco treatment in addiction service settings is well received by clients who are motivated to quit smoking.

Document Type

Presentation

Publication Date

6-2012

Notes/Citation Information

A presentation for the UK National Smoking Cessation Conference, Birmingham, UK.

Download

Share

COinS